Brought to you by 
MediGene gets $102.5mm with IPO
26 Jul 2000
Executive Summary
MediGene (therapeutics for cancer and cardiovascular disease) went public on the Neuer Markt with the sale of 2.6mm shares priced at $39.65 (Euro42) each, raising a total of $102.5mm.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Vaccines
-
Biotechnology
- Drug Discovery Tools
- Gene Therapy, Cell Therapy
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com